ARTICLE | Company News
Remedyne, University of California deal
December 9, 2002 8:00 AM UTC
Remedyne received an exclusive worldwide license from the Regents of the University of California to patents covering immune stimulation technology. Therapeutic vaccines using the technology cause the...